We therefore suggest that increased IGFBP-3 level maybe a key mediator of the association between BC risk, the IGFBP-3 rs2854744 AA genotype, DISI<9.85 mg/day, and BMI ≥24 kg/m2 in our study population. This evidence concerns the gene IGFBP3 and breast cancer.